Evidence map›Paper›PMID 24317697›Full record

ArticleNature2014

Structural basis of the alternating-access mechanism in a bile acid transporter.

Xiaoming Zhou, Elena J Levin, Yaping Pan, Jason G McCoy, Ruchika Sharma, Brian Kloss, Renato Bruni, Matthias Quick, Ming Zhou

Open access · greenAbstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Hepatitis B and D virus entry.Nature reviews. Microbiology · 2025
    Review
  11. Genome-Wide Identification and Expression Analysis ofCurrent issues in molecular biology · 2024
    Article
  12. Molecular mechanisms of NaBiophysical journal · 2024
    Article
  13. Review
  14. The utilisation of biliary organoids for biomedical applications.Frontiers in bioengineering and biotechnology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiaoming Zhou1] Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA [2] Department of Physiology and Cellular Biophysics, Columbia University, New York, New York 10032, USA [3].
Elena J Levin1] Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA [2].
Yaping PanVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Jason G McCoyVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Ruchika SharmaDepartment of Physiology and Cellular Biophysics, Columbia University, New York, New York 10032, USA.
Brian KlossNew York Consortium on Membrane Protein Structure, New York, New York 10027, USA.
Renato BruniNew York Consortium on Membrane Protein Structure, New York, New York 10027, USA.
Matthias Quick1] Department of Psychiatry and Center for Molecular Recognition, Columbia University, New York, New York 10032, USA [2] New York State Psychiatric Institute, Division of Molecular Therapeutics, New York, New York 10032, USA.
Ming Zhou1] Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA [2] Department of Physiology and Cellular Biophysics, Columbia University, New York, New York 10032, USA [3] Ion Channel Research and Drug Development Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.
Baylor College of Medicine · USColumbia University · USNew York Structural Biology Center · US

Funding

Synthetic Antigen Binder CoreU54GM087519 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHOU, MING · 2010 to 2017
$31.9M
Sub 9 at AECMU54GM075026 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI HUNT, JOHN FRANCIS · 2005 to 2009
$16.8M
Structural Genomics on Membrane ProteinsU54GM095315 · NIGMS · NEW YORK STRUCTURAL BIOLOGY CENTER · PI ROST, BURKHARD · 2010 to 2014
$15.2M
Structure and function of urea transportersR01DK088057 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHOU, MING · 2010 to 2014
$1.7M
Structure and Function of a Phosphorylation Coupled Saccharide TransporterR01GM098878 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHOU, MING · 2011 to 2014
$1.2M
NIDDK NIH HHS R01 DK088057NIDDK NIH HHS R01DK088057NIGMS NIH HHS R01 GM098878NIGMS NIH HHS R01GM098878NIGMS NIH HHS U54 GM075026NIGMS NIH HHS U54 GM087519NIGMS NIH HHS U54GM087519NIGMS NIH HHS U54 GM095315NIGMS NIH HHS U54GM095315
6 · The paper itself

Abstract

Bile acids are synthesized from cholesterol in hepatocytes and secreted through the biliary tract into the small intestine, where they aid in absorption of lipids and fat-soluble vitamins. Through a process known as enterohepatic recirculation, more than 90% of secreted bile acids are then retrieved from the intestine and returned to the liver for resecretion. In humans, there are two Na(+)-dependent bile acid transporters involved in enterohepatic recirculation, the Na(+)-taurocholate co-transporting polypeptide (NTCP; also known as SLC10A1) expressed in hepatocytes, and the apical sodium-dependent bile acid transporter (ASBT; also known as SLC10A2) expressed on enterocytes in the terminal ileum. In recent years, ASBT has attracted much interest as a potential drug target for treatment of hypercholesterolaemia, because inhibition of ASBT reduces reabsorption of bile acids, thus increasing bile acid synthesis and consequently cholesterol consumption. However, a lack of three-dimensional structures of bile acid transporters hampers our ability to understand the molecular mechanisms of substrate selectivity and transport, and to interpret the wealth of existing functional data. The crystal structure of an ASBT homologue from Neisseria meningitidis (ASBT(NM)) in detergent was reported recently, showing the protein in an inward-open conformation bound to two Na(+) and a taurocholic acid. However, the structural changes that bring bile acid and Na(+) across the membrane are difficult to infer from a single structure. To understand the structural changes associated with the coupled transport of Na(+) and bile acids, here we solved two structures of an ASBT homologue from Yersinia frederiksenii (ASBTYf) in a lipid environment, which reveal that a large rigid-body rotation of a substrate-binding domain gives the conserved 'crossover' region, where two discontinuous helices cross each other, alternating accessibility from either side of the cell membrane. This result has implications for the location and orientation of the bile acid during transport, as well as for the translocation pathway for Na(+).

Indexed as

Bacterial ProteinsBile Acids and SaltsBiological TransportCarrier ProteinsCell MembraneCrystallography, X-RayMembrane GlycoproteinsModels, MolecularProtein ConformationReproducibility of ResultsRotationSodiumStructure-Activity RelationshipYersiniaBacterial Proteinsbile acid binding proteinsBile Acids and SaltsCarrier ProteinsMembrane GlycoproteinsSodium

Identifiers

PMID24317697
PMCPMC4142352
OpenAlexW2074979419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.